Our next goal was to analyze the impact of the studied nanoformulations on the NF-κB pathway, a crucial signaling pathway frequently activated in GBM cells and implicated in various aspects of tumor development, including the maintenance of glioma stem cells, invasion, and resistance to treatment. This evidence concerns the gene NFKB1 and central nervous system cancer.